Docket Room.
S 5004·Federal·senate

Cancer Drug Parity Act of 2026

In CommitteeFiled Jul 15, 2026
Sponsor: Sen. Smith, Tina [D-MN] (D)
Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jul 15, 2026

Email me when S 5004 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track S 5004. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill amends ERISA so that any group health plan must provide cost‑sharing for oral anticancer medicines on terms no less favorable than for anticancer drugs administered by a health‑care provider. It applies to employees and their dependents who receive coverage through such plans. The goal is to prevent higher out‑of‑pocket costs for oral cancer pills compared with infused treatments.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about S 5004

3 free questions a day, no account

Sponsors

  • Sen. Smith, Tina [D-MN] (D) · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when S 5004 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track S 5004 free

Or ask your AI assistant about S 5004 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice